State of melanoma: an historic overview of a field in transition.
about
Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma.Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.Ensemble Modeling Approach Targeting Heterogeneous RNA-Seq data: Application to Melanoma Pseudogenes.Sifting Through It All: Characterizing Melanoma Patients' Utilization of the Internet as an Information Source.Targeting immune checkpoints in melanoma: an updateEvaluation of In Vitro Antioxidant and Anticancer Properties of the Aqueous Extract from the Stem Bark of
P2860
State of melanoma: an historic overview of a field in transition.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
State of melanoma: an historic overview of a field in transition.
@ast
State of melanoma: an historic overview of a field in transition.
@en
type
label
State of melanoma: an historic overview of a field in transition.
@ast
State of melanoma: an historic overview of a field in transition.
@en
prefLabel
State of melanoma: an historic overview of a field in transition.
@ast
State of melanoma: an historic overview of a field in transition.
@en
P2860
P1476
State of melanoma: an historic overview of a field in transition.
@en
P2093
John M Kirkwood
Vikram C Gorantla
P2860
P304
P356
10.1016/J.HOC.2014.02.010
P577
2014-06-01T00:00:00Z